Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial.

Assaf GershoniAlon TiosanoMeydan Ben IshaiEdward BarayevGuy J Ben SimonIftach Yassur

Published in: Eye (London, England) (2021)

Secondary analysis of the results of the STEVIE trial showed that the HRQoL of patients with POLA-BCC is significantly impaired and can be greatly improved with vismodegib treatment.

Keyphrases

basal cell carcinoma
phase iii
locally advanced
study protocol
phase ii
clinical trial
squamous cell carcinoma
open label
rectal cancer
neoadjuvant chemotherapy
randomized controlled trial
phase ii study
combination therapy
double blind
placebo controlled